Table 3.
Effect of Intervention Bundle on Clinical Cultures and Blood Culture Contamination
| Outcome | Preinterventiona |
Interventiona |
Change in Event Rate |
P Value |
||||
|---|---|---|---|---|---|---|---|---|
| No. of Events |
Events/1000 Patient-days |
95% CI | No. of Events |
Events/1000 Patient-days |
95% CI | |||
| KPC in any clinical culture | 656 | 3.7 | 3.4–4.0 | 285 | 2.5 | 2.2–2.8 | −1.2 | .001 |
| KPC bloodstream infection | 165 | 0.9 | .8–1.1 | 48 | 0.4 | .3-.5 | −0.5 | .008 |
| Bloodstream infection due to any pathogen | 2004 | 11.2 | 10.7–11.7 | 870 | 7.6 | 7.1–8.1 | −3.6 | .006 |
| Contaminated blood culture | 865 | 4.9 | 4.5–5.2 | 261 | 2.3 | 2.0–2.6 | −2.6 | .03 |
Abbreviations: CI, confidence interval; KPC, Klebsiella pneumoniae carbapenemase–producing Enterobacteriaceae.
There were 178 516 patient-days in the preintervention period and 114 070 patient-days in the intervention period.